Company / Operating Cash Flow
Alkermes plc Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$520.8M
FY2025
5-year range
$21.0M / $520.8M
FY2021-FY2025
Trend
+18.6%
vs FY2024
Sector context
#30 of 216
Health Care
What the data says
Alkermes plc's operating cash flow of $521M is higher than 86% of companies in the Health Care sector (FY2025). Operating Cash Flow has increased for 3 consecutive years, from $21M in FY2022 to $521M in FY2025.
Based on SEC 10-K filings.
$521M in FY2025 with a 5-year CAGR of +44.4%. Top quartile in the Health Care sector.
Improved from $401M to $521M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +191.4%
- 5-Year CAGR
- +44.4%
- 10-Year CAGR
- -
Sector benchmark
-20.9% below sector average
Key checks
Key Insights
- Alkermes plc's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +44.4%, indicating consistent growth.
- In FY2025, operating cash flow increased 18.6% year-over-year.
- Ranks #30 out of 216 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $520.8M | +18.6% |
| FY2024 | $439.1M | +9.4% |
| FY2023 | $401.4M | +1807.2% |
| FY2022 | $21.0M | -79.3% |
| FY2021 | $101.7M | +22.8% |
| FY2020 | $82.8M | +14.9% |
| FY2019 | $72.1M | -27.4% |
| FY2018 | $99.3M | +417.4% |
| FY2017 | $19.2M | +130.1% |
| FY2016 | -$63.8M | -143.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026